# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-010967
Filing Date
2024-08-06
Accepted
2024-08-06 09:05:34
Documents
87
Period of Report
2024-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | btai-20240630x10q.htm iXBRL | 10-Q | 2436830
2 | EX-10.1 | btai-20240630xex10d1.htm | EX-10.1 | 30740
3 | EX-31.1 | btai-20240630xex31d1.htm | EX-31.1 | 17375
4 | EX-31.2 | btai-20240630xex31d2.htm | EX-31.2 | 17594
5 | EX-32.1 | btai-20240630xex32d1.htm | EX-32.1 | 10355
6 | EX-32.2 | btai-20240630xex32d2.htm | EX-32.2 | 8788
7 | GRAPHIC | btai-20240630x10q006.jpg | GRAPHIC | 87847
8 | GRAPHIC | btai-20240630x10q007.jpg | GRAPHIC | 80261
| Complete submission text file | 0001558370-24-010967.txt |  | 9579881

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | EX-101.SCH | btai-20240630.xsd | EX-101.SCH | 53672
10 | EX-101.CAL | btai-20240630_cal.xml | EX-101.CAL | 45706
11 | EX-101.DEF | btai-20240630_def.xml | EX-101.DEF | 264830
12 | EX-101.LAB | btai-20240630_lab.xml | EX-101.LAB | 509431
13 | EX-101.PRE | btai-20240630_pre.xml | EX-101.PRE | 416721
90 | EXTRACTED XBRL INSTANCE DOCUMENT | btai-20240630x10q_htm.xml | XML | 1378135

Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

EIN.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38410 | Film No.: 241177290
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)